Surgery is considered the treatment of choice for patients with resectable stage I and II (and some patients with stage IIIA)non-small cell lung cancer (NSCLC), but there have been no previously published systematic reviews. METHODS: A systematic review and meta-analysis of randomised controlled trials was conducted to determine whether surgical resection improves disease specific mortality in patients with stages I-IIIA NSCLC compared with non-surgical treatment, and to compare the efficacy of different surgical approaches. RESULTS: Eleven trials were included. No studies had untreated control groups.
|Pages (from-to)||597 - 603|
|Number of pages||7|
|Publication status||Published - 2006|